The Ministry of Health proposed to expand the drug program for patients with severe dyslipidemia The Russian Ministry of Health prepared a draft decision that allows the expansion of the federal program of providing free drugs to patients with cardiovascular diseases. It is proposed to allocate an additional 1.6 billion rubles annually for these purposes in 2027-2029. The changes will affect patients with dyslipidemia who are under clinical follow-up after stroke, myocardial infarction or cardiovascular interventions. The draft specifies additional criteria: an early atherosclerotic cardiovascular event and (or) an excess of one of the lipid metabolism indicators: total cholesterol - more than 8 mmol/l; low-density lipoprotein cholesterol - more than 5 mmol/l; Triglycerides - more than 10 mmol/l. For this category of patients, medication is provided for two years from the date of diagnosis and (or) surgical intervention. According to the explanatory note, the additional need for financing is 1.597 billion rubles per year. The government committee for budgetary projects ordered the Ministry of Finance, together with the Ministry of Health, to take these costs into account when preparing the amendments to the draft federal budget for the years 2027-2029 for a second reading. The expansion of the program is planned to be carried out through federal subsidies to the regions as part of the "Combating Cardiovascular Diseases" project. In order to implement the changes, it will also be necessary to adjust the Ministry of Health regulations governing the list of medicines for supplying patients outside. Read us in Max Telegram VK.